Pathophysiological impact of transcellular metabolism for the induction of clinical aspirin resistance.
Kannan
Subburaj
S
D000818:Animals; D001241:Aspirin / Q000008:administration & dosage* / Q000276:immunology*; D051546:Cyclooxygenase 2 / Q000276:immunology*; D052246:Cyclooxygenase 2 Inhibitors / Q000008:administration & dosage / Q000276:immunology; D016207:Cytokines / Q000276:immunology*; D004351:Drug Resistance / Q000276:immunology*; D006801:Humans; D018448:Models, Immunological; D018375:Neutrophil Activation / Q000187:drug effects / Q000276:immunology*
D052246:Cyclooxygenase 2 Inhibitors; D016207:Cytokines; D051546:Cyclooxygenase 2; D001241:Aspirin